IBM gives cancer-killing drug AI projects to the open source community
Researchers from IBM’s Computational Systems Biology group in Zurich are working on AI and machine learning (ML) approaches to “help to accelerate our understanding of the leading drivers and molecular mechanisms of these complex diseases,” as well as methods to improve our knowledge of tumor composition. “Our goal is to deepen our understanding of cancer Read more about IBM gives cancer-killing drug AI projects to the open source community[…]